Lion Share Creates Billionaire
Historically, lion’s share meant obtaining the whole thing. In today’s vernacular it is defined as obtaining the largest portion of a thing. Well, whichever way you slice it, the bottom line is the medical field is staking a large claim to bioinformatics.
Bioinformatics allows for the electronic analysis and interpretation of complex biological information through the use of software technologies. In other words, this field links clinical data with information technology (IT) into accessible data bases to tailor treatment and research based on sequences.
Because of the capabilities of the technology bioinformatics is big business, particularly in the area of genomics. Some business leaders estimate the current value of bioinformatics to be $7.3 billion industry, with rapid future growth.
Of all of the sectors that utilizes bioinformatics technology, including but not limited to academia, agriculture, environmental services and forensics, the medical arena is value in the billions above all of the other sectors. The medical sector includes biotechnology, laboratory science and pharmaceuticals.
I think that the fact that the bioinformatics industry is bounding into the billions and there appears to be no ceiling is important. The global interplay for medicine, drug discovery and innovative approaches will only increase laboratories and employment opportunities to meet the need for this technology. The medical sector accounted for the lion's share of the bioinformatics market, owing to the increasing use of bioinformatics in the drug discovery and development process. It is predicted that this sector will produce stock market billionaires similar to the technology dot com era.
This is an emerging science which will play an important role in computational molecular biology, genetics and genomics. This approach will usher in a new way to quickly screen, identify and measure diseases. The work efforts of clinical and research laboratorians will be significantly enriched by bioinformatics tools.